Austin, TX, United States of America

Andreas Gebauer


Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Andreas Gebauer

Introduction

Andreas Gebauer is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of chemistry, particularly in the development of macrocyclic compounds. His work has led to advancements in ion and neutral molecule-binding agents, which have various applications in environmental remediation and chromatography.

Latest Patents

Andreas Gebauer holds 2 patents related to calixpyrroles, calixpyridinopyrroles, and calixpyridine macrocycles. His latest patents describe the synthesis and application of these macrocycles, which consist of 4 to 8 heterocyclic rings. These compounds have demonstrated effectiveness as selective binding agents for ions and neutral molecules, forming supramolecular ensembles. The binding mode is primarily noncovalent, utilizing hydrogen-bonding, which introduces a new method for liquid chromatography known as Hydrogen Bonding Liquid Chromatography. Additionally, these macrocycles have potential applications in environmental remediation, including the removal of undesired ions and neutral molecules, as well as phosphate removal for kidney dialysis.

Career Highlights

Andreas Gebauer is affiliated with the University of Texas System, where he continues to innovate and contribute to scientific research. His work has garnered attention for its practical applications and contributions to the field of chemistry.

Collaborations

Andreas has collaborated with notable scientists such as Philip A Gale and Jonathan L Sessler, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Andreas Gebauer's innovative work in the field of macrocyclic compounds has opened new avenues for research and practical applications. His contributions are significant in advancing the understanding and utilization of ion and neutral molecule-binding agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…